LCM
VOR icon

Laurion Capital Management’s Vor Biopharma VOR Stock Holding History

Laurion Capital Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-318,670
Closed -$5.69M – 564
2026
Q1 		$5.69M Buy
318,670
+1,427
+0.4% +$20.1K 0.25% 113
2025
Q4 		$4.15M Buy
+317,243
New +$5.91M 0.15% 83
2024
Q4 		– Sell
-1,449
Closed -$20.3K – 390
2024
Q3 		$20.3K Sell
1,449
-124,823
-99% -$2.28M ﹤0.01% 265
2024
Q2 		$2.53M Sell
126,272
-32,872
-21% -$1.06M 0.03% 203
2024
Q1 		$7.54M Hold
159,144
– – 0.06% 219
2023
Q4 		$7.16M Hold
159,144
– – 0.06% 217
2023
Q3 		$6.75M Hold
159,144
– – 0.04% 251
2023
Q2 		$9.84M Hold
159,144
– – 0.06% 217
2023
Q1 		$17.1M Hold
159,144
– – 0.12% 161
2022
Q4 		$21.2M Buy
159,144
+116,279
+271% +$11.5M 0.1% 171
2022
Q3 		$3.41M Hold
42,865
– – 0.02% 286
2022
Q2 		$4.26M Hold
42,865
– – 0.07% 179
2022
Q1 		$5.18M Hold
42,865
– – 0.06% 162
2021
Q4 		$9.96M Buy
42,865
+10,000
+30% +$2.88M 0.1% 133
2021
Q3 		$10.3M Buy
32,865
+3,582
+12% +$1.06M 0.04% 268
2021
Q2 		$10.9M Hold
29,283
– – 0.06% 204
2021
Q1 		$25.2M Buy
+29,283
New +$24.8M 0.14% 148

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Laurion Capital Management's VOR Position: Q2 2026 in Review

Laurion Capital Management sold out of Vor Biopharma (VOR) in Q2 2026, closing a stake of 318,670 shares — an estimated $5.69M sold.

Laurion Capital Management first reported a position in VOR in Q1 2021 and held it in 17 quarters. The position peaked at $25.2M in Q1 2021. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Laurion Capital Management reported no remaining Vor Biopharma position as of Q2 2026 after selling out during the quarter.
  • Laurion Capital Management sold 318,670 Vor Biopharma shares in Q2 2026, an estimated $5.69M.
  • Laurion Capital Management first reported a position in Vor Biopharma in Q1 2021 and held it in 17 quarters.
  • Laurion Capital Management's Vor Biopharma position peaked at $25.2M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.